21世纪骨髓转移成像的发展概念：FDG-PET的关键作用 - Suppr

Suppr

超能文献

Evolving concept of imaging bone marrow metastasis in the twenty-first century: critical role of FDG-PET.

作者信息

Basu Sandip, Torigian Drew, Alavi Abass

出版信息

Eur J Nucl Med Mol Imaging. 2008 Mar;35(3):465-71. doi: 10.1007/s00259-007-0593-0.

DOI:10.1007/s00259-007-0593-0

PMID:17955239

Abstract

摘要

相似文献

Evolving concept of imaging bone marrow metastasis in the twenty-first century: critical role of FDG-PET.

Eur J Nucl Med Mol Imaging. 2008 Mar;35(3):465-71. doi: 10.1007/s00259-007-0593-0.

Bone metastasis versus bone marrow metastasis? Integration of diagnosis by (18)F-fluorodeoxyglucose positron emission/computed tomography in advanced malignancy with super bone scan: two case reports and literature review.

Kaohsiung J Med Sci. 2013 Apr;29(4):229-33. doi: 10.1016/j.kjms.2012.08.038. Epub 2012 Nov 29.

Positron emission tomography and bone metastases.

Semin Nucl Med. 2005 Apr;35(2):135-42. doi: 10.1053/j.semnuclmed.2004.11.005.

Bone marrow metastases from alveolar rhabdomyosarcoma with impressive FDG PET/CT finding but less-revealing bone scintigraphy.

Clin Nucl Med. 2013 Dec;38(12):988-91. doi: 10.1097/RLU.0000000000000277.

PET/CT in primary musculoskeletal tumours: a step forward.

Eur Radiol. 2010 Dec;20(12):2959-72. doi: 10.1007/s00330-010-1862-z. Epub 2010 Jun 25.

FDG PET/CT flip flop phenomenon in treated lymphoma of bone.

Clin Nucl Med. 2006 Dec;31(12):803-5. doi: 10.1097/01.rlu.0000246858.03018.0c.

CT imaging of bone and bone marrow infiltration in malignant melanoma--Challenges and limitations for clinical staging in comparison to 18FDG-PET/CT.

Eur J Radiol. 2016 Apr;85(4):732-8. doi: 10.1016/j.ejrad.2016.01.012. Epub 2016 Jan 19.

Detection of bone marrow metastases by FDG-PET and missed by bone scintigraphy in widespread melanoma.

Clin Nucl Med. 2005 Sep;30(9):606-7. doi: 10.1097/01.rlu.0000174200.67064.28.

Bone marrow and not bone is the primary site for skeletal metastasis: critical role of [18F]fluorodeoxyglucose positron emission tomography in this setting.

J Clin Oncol. 2007 Apr 1;25(10):1297; author reply 1297-9. doi: 10.1200/JCO.2006.10.0123.

A meta-analysis of ¹⁸FDG-PET-CT, ¹⁸FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer.

Eur J Radiol. 2012 May;81(5):1007-15. doi: 10.1016/j.ejrad.2011.01.126. Epub 2011 Feb 26.

引用本文的文献

Is It Time to Call Time on Bone Marrow Biopsy for Staging Ewing Sarcoma (ES)?

Cancers (Basel). 2021 Jun 29;13(13):3261. doi: 10.3390/cancers13133261.

The value of prebiopsy FDG-PET/CT in discriminating malignant from benign vertebral bone lesions in a predominantly oncologic population.

Skeletal Radiol. 2020 Sep;49(9):1387-1395. doi: 10.1007/s00256-020-03426-8. Epub 2020 Apr 6.

Simultaneous PET/MRI in the Evaluation of Breast and Prostate Cancer Using Combined Na[F]F and [F]FDG: a Focus on Skeletal Lesions.

Mol Imaging Biol. 2020 Apr;22(2):219-220. doi: 10.1007/s11307-019-01449-9.

Cancer metastasizes to the bone marrow and not to the bone: time for a paradigm shift!

Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):893-897. doi: 10.1007/s00259-018-3959-6.

Increasing Role of FDG-PET/CT in Detecting Bone Marrow Metastasis of Solid Tumors in Adults: An Analysis of Ten Patients.

World J Oncol. 2012 Dec;3(6):271-279. doi: 10.4021/wjon598w. Epub 2013 Jan 4.

Evolving Role of Molecular Imaging with (18)F-Sodium Fluoride PET as a Biomarker for Calcium Metabolism.

Curr Osteoporos Rep. 2016 Aug;14(4):115-25. doi: 10.1007/s11914-016-0312-5.

Comparisons between glucose analogue 2-deoxy-2-((18)F)fluoro-D-glucose and (18)F-sodium fluoride positron emission tomography/computed tomography in breast cancer patients with bone lesions.

World J Radiol. 2016 Feb 28;8(2):200-9. doi: 10.4329/wjr.v8.i2.200.

Evaluation of radiographic and metabolic changes in bone metastases in response to systemic therapy with (18)FDG-PET/CT.

Radiol Oncol. 2015 Mar 25;49(2):115-20. doi: 10.1515/raon-2015-0012. eCollection 2015 Jun.

Critical considerations on the combined use of ¹⁸F-FDG and ¹⁸F-fluoride for PET assessment of metastatic bone disease.

Eur J Nucl Med Mol Imaging. 2013 Aug;40(8):1141-5. doi: 10.1007/s00259-013-2459-y. Epub 2013 May 22.

Whole-body MRI for the detection of bone marrow involvement in lymphoma: prospective study in 116 patients and comparison with FDG-PET.

Eur Radiol. 2013 Aug;23(8):2271-8. doi: 10.1007/s00330-013-2835-9. Epub 2013 Apr 17.

本文引用的文献

Bone and marrow imaging: do we know what we see and do we see what we want to know?

Eur J Nucl Med Mol Imaging. 2007 Jul;34(7):1123-6. doi: 10.1007/s00259-007-0473-7.

Novel quantitative techniques for assessing regional and global function and structure based on modern imaging modalities: implications for normal variation, aging and diseased states.

Semin Nucl Med. 2007 May;37(3):223-39. doi: 10.1053/j.semnuclmed.2007.01.005.

Structural and functional imaging of normal bone marrow and evaluation of its age-related changes.

Semin Nucl Med. 2007 May;37(3):185-94. doi: 10.1053/j.semnuclmed.2007.01.002.

Bone marrow and not bone is the primary site for skeletal metastasis: critical role of [18F]fluorodeoxyglucose positron emission tomography in this setting.

J Clin Oncol. 2007 Apr 1;25(10):1297; author reply 1297-9. doi: 10.1200/JCO.2006.10.0123.

Detection of cytokeratin-positive cells in the bone marrow of breast cancer patients undergoing adjuvant therapy.

Breast Cancer Res Treat. 2006 May;97(1):91-6. doi: 10.1007/s10549-005-9095-6. Epub 2005 Dec 1.

CT appearance of bone metastases detected with FDG PET as part of the same PET/CT examination.

Radiology. 2005 Nov;237(2):627-34. doi: 10.1148/radiol.2372031994.

The emerging role of CD44 in regulating skeletal micrometastasis.

Cancer Lett. 2006 Jun 8;237(1):1-9. doi: 10.1016/j.canlet.2005.05.006. Epub 2005 Jun 27.

Fluorodeoxyglucose-PET in characterizing solitary pulmonary nodules, assessing pleural diseases, and the initial staging, restaging, therapy planning, and monitoring response of lung cancer.

Radiol Clin North Am. 2005 Jan;43(1):1-21, ix. doi: 10.1016/j.rcl.2004.09.001.

Evolving role of positron emission tomography in the management of patients with inflammatory and other benign disorders.

Semin Nucl Med. 2004 Oct;34(4):313-29. doi: 10.1053/j.semnuclmed.2004.06.006.

Fluorodeoxyglucose-PET in the management of breast cancer.

Radiol Clin North Am. 2004 Nov;42(6):1113-22, ix. doi: 10.1016/j.rcl.2004.08.005.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验